TY  - GEN
AU  - Wang,Zhijie
AU  - Duan,Jianchun
AU  - Cai,Shangli
AU  - Han,Miao
AU  - Dong,Hua
AU  - Zhao,Jun
AU  - Zhu,Bo
AU  - Wang,Shuhang
AU  - Zhuo,Minglei
AU  - Sun,Jianguo
AU  - Wang,Qiming
AU  - Bai,Hua
AU  - Han,Jiefei
AU  - Tian,Yanhua
AU  - Lu,Jing
AU  - Xu,Tongfu
AU  - Zhao,Xiaochen
AU  - Wang,Guoqiang
AU  - Cao,Xinkai
AU  - Li,Fugen
AU  - Wang,Dalei
AU  - Chen,Yuejun
AU  - Bai,Yuezong
AU  - Zhao,Jing
AU  - Zhao,Zhengyi
AU  - Zhang,Yuzi
AU  - Xiong,Lei
AU  - He,Jie
AU  - Gao,Shugeng
AU  - Wang,Jie
TI  - Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
SN  - 2374-2445
PY  - 2020///0210
KW  - Aged
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - B7-H1 Antigen
KW  - antagonists & inhibitors
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Carcinoma, Non-Small-Cell Lung
KW  - blood
KW  - Circulating Tumor DNA
KW  - Female
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Immunotherapy
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Programmed Cell Death 1 Receptor
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1001/jamaoncol.2018.7098
ER  -